Polaris Venture Management Co. V, L.L.C.

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$48.2M
Insider Sells Quantity
17
Insider Sells Sum
$87.71M

Insider Activity of Polaris Venture Management Co. V, L.L.C.

The largest purchase of all time was on 2014-04-15 and amounted to 2941164 shares of Daré Bioscience, Inc. for $20.59M.

The largest sale of all time was on 2015-02-02 and amounted to 1000000 shares of Ocular Therapeutix, Inc. for $29.5M.

Biography of Polaris Venture Management Co. V, L.L.C.

No biography is available at this moment.

2020-05-05SaleLyra Therapeutics, Inc.
LYRA
10 percent owner
9,674
0.1136%
$16.00$154,784-28.92%
2020-05-05PurchaseLyra Therapeutics, Inc.
LYRA
10 percent owner
62,500
0.734%
$16.00$1M-28.92%
2019-12-17SalePhreesia, Inc.
PHR
10 percent owner
714,242
1.8667%
$24.48$17.48M+13.88%
2019-07-22SalePhreesia, Inc.
PHR
10 percent owner
793,598
8.7688%
$18.00$14.28M+13.72%
2019-07-17SaleCardlytics, Inc.
CDLX
10 percent owner
55,562
0.2345%
$27.45$1.53M+76.85%
2019-07-16SaleCardlytics, Inc.
CDLX
10 percent owner
41,924
0.1793%
$27.87$1.17M+76.17%
2019-07-15SaleCardlytics, Inc.
CDLX
10 percent owner
39,968
0.1701%
$27.73$1.11M+74.5%
2019-06-07SaleCardlytics, Inc.
CDLX
10 percent owner
200,000
0.8717%
$25.62$5.12M+61.33%
2019-06-06SaleCardlytics, Inc.
CDLX
10 percent owner
610
0.0027%
$25.00$15,250+70.29%
2019-06-05SaleCardlytics, Inc.
CDLX
10 percent owner
77,202
0.3378%
$24.86$1.92M+66.83%
2019-06-04SaleCardlytics, Inc.
CDLX
10 percent owner
72,756
0.3204%
$23.28$1.69M+79.02%
2019-05-28SaleCardlytics, Inc.
CDLX
10 percent owner
200,000
0.8607%
$23.04$4.61M+72.4%
2018-09-13SaleCardlytics, Inc.
CDLX
100,000
0.4784%
$25.56$2.56M-24.65%
2018-09-12SaleCardlytics, Inc.
CDLX
200,000
0.9309%
$24.78$4.96M-24.38%
2017-11-20PurchaseX4 Pharmaceuticals, Inc.
XFOR
10 percent owner
1M
33.541%
$10.00$10M-10.41%
2015-02-02SaleOcular Therapeutix, Inc.
OCUL
10 percent owner
1M
4.5025%
$29.50$29.5M-32.31%
2014-08-14SaleTrevena, Inc.
TRVN
director
73,404
0.2812%
$6.04$443,360-0.42%
2014-08-13SaleTrevena, Inc.
TRVN
director
11,400
0.0438%
$6.12$69,768-1.41%
2014-04-15PurchaseDaré Bioscience, Inc.
DARE
10 percent owner
2.94M
18.5886%
$7.00$20.59M-11.51%
2014-02-05SaleTrevena, Inc.
TRVN
director
974,264
–
$1.13$1.1M-14.1%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.